The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
The relationship between COPD and lung cancer
Open accessAbstract
Both COPD and lung cancer are major worldwide health concerns owing to cigarette smoking, and represent a huge, worldwide, preventable disease burden. Whilst the majority of smokers will not develop either COPD or lung cancer, they are closely related diseases, occurring as co-morbidities at a higher rate than if they were independently triggered by smoking. Lung cancer and COPD may be different aspects of the same disease, with the same underlying predispositions, whether this is an underlying genetic predisposition, telomere shortening, mitochondrial dysfunction or premature aging. In the majority of smokers, the burden of smoking may be dealt with by the body's defense mechanisms: anti-oxidants such as superoxide dismutases, anti-proteases and DNA repair mechanisms. However, in the case of both diseases these fail, leading to cancer if mutations occur or COPD if damage to the cell and proteins becomes too great. Alternatively COPD could be a driving factor in lung cancer, by increasing oxidative stress and the resulting DNA damage, chronic exposure to pro-inflammatory cytokines, repression of the DNA repair mechanisms and increased cellular proliferation. Understanding the mechanisms that drive these processes in primary cells from patients with these diseases along with better disease models is essential for the development of new treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Non-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
The natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 3×
“Inflammation s a key source of RNOS [33] and RNOS levels are persistently high n COPD.”
BackgroundInfluentialColony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Free-radical chemistry of cigarette smoke and its toxicological implications.
Church, D. F., & Pryor, W. A. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.8564111 · Cited by 1,441
Schreck, R., Albermann, K., & Baeuerle, P. A. (1992) · Free Radical Research Communications · doi:10.3109/10715769209079515 · Cited by 1,401
Rodríguez, R. (2007) · Cited by 1,391
Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitritea
PRYOR, W. A., & STONE, K. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb39148.x · Cited by 1,152
Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968
Self-citationRole of oxidative stress and DNA damage in human carcinogenesis
Kryston, T. B., Georgiev, A. B., Pissis, P., & Georgakilas, A. G. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2010.12.016 · Cited by 930
Antioxidants Accelerate Lung Cancer Progression in Mice
Sayin, V. I., Ibrahim, M. X., Larsson, E., Nilsson, J. A., Lindahl, P., & Bergo, M. O. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007653 · Cited by 867
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
Management of non-small-cell lung cancer: recent developments
Reck, M., Heigener, D. F., Mok, T., Soria, J.-C., & Rabe, K. F. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61502-0 · Cited by 714
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
LUNDBÄCK, B., LINDBERG, A., LINDSTRÖM, M., RÖNMARK, E., JONSSON, A. C., JÖNSSON, E., LARSSON, L.-G., ANDERSSON, S., SANDSTRÖM, T., & LARSSON, K. (2003) · Respiratory Medicine · doi:10.1053/rmed.2003.1446 · Cited by 643
COPD as a Disease of Accelerated Lung Aging
Ito, K., & Barnes, P. J. (2009) · Chest · doi:10.1378/chest.08-1419 · Cited by 629
Oxidative stress, DNA methylation and carcinogenesis
Franco, R., Schoneveld, O., Georgakilas, A. G., & Panayiotidis, M. I. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.026 · Cited by 603
Free Radical Theory of Aging: An Update: Increasing the Functional Life Span
HARMAN, D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.003 · Cited by 601
Telomere Dysfunction: A Potential Cancer Predisposition Factor
Wu, X., Amos, C. I., Zhu, Y., Zhao, H., Grossman, B. H., Shay, J. W., Luo, S., Hong, W. K., & Spitz, M. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg011 · Cited by 494
Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity.
Pryor, W. A. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s4875 · Cited by 479
Telomeres: Cancer to Human Aging
Stewart, S. A., & Weinberg, R. A. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104518 · Cited by 334
T helper 17 cells play a critical pathogenic role in lung cancer
Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319051111 · Cited by 326
Telomere shortening in smokers with and without COPD
Morlá, M., Busquets, X., Pons, J., Sauleda, J., MacNee, W., & Agustí, A. G. N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00087005 · Cited by 326
Shortened Telomeres in Circulating Leukocytes of Patients with Chronic Obstructive Pulmonary Disease
Savale, L., Chaouat, A., Bastuji-Garin, S., Marcos, E., Boyer, L., Maitre, B., Sarni, M., Housset, B., Weitzenblum, E., Matrat, M., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1398oc · Cited by 322
Hoffmann, R. F., Zarrintan, S., Brandenburg, S. M., Kol, A., de Bruin, H. G., Jafari, S., Dijk, F., Kalicharan, D., Kelders, M., Gosker, H. R., et al. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-97 · Cited by 316
Global and regional trends in COPD mortality, 1990–2010
Burney, P. G. J., Patel, J., Newson, R., Minelli, C., & Naghavi, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00142414 · Cited by 311
MicroRNA in the immune system, microRNA as an immune system
Lu, L., & Liston, A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03092.x · Cited by 300
A Translational View of the Molecular Pathogenesis of Lung Cancer
Sato, M., Shames, D. S., Gazdar, A. F., & Minna, J. D. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000263718.69320.4c · Cited by 297
Ridge, C., McErlean, A., & Ginsberg, M. (2013) · Seminars in Interventional Radiology · doi:10.1055/s-0033-1342949 · Cited by 295
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Shen, H.-M., & Tergaonkar, V. (2009) · Apoptosis · doi:10.1007/s10495-009-0315-0 · Cited by 275
Telomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265
Telomere Dysfunction Causes Sustained Inflammation in Chronic Obstructive Pulmonary Disease
Amsellem, V., Gary-Bobo, G., Marcos, E., Maitre, B., Chaar, V., Validire, P., Stern, J.-B., Noureddine, H., Sapin, E., Rideau, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0802oc · Cited by 264
Erhola, M., Toyokuni, S., Okada, K., Tanaka, T., Hiai, H., Ochi, H., Uchida, K., Osawa, T., Nieminen, M. M., Alho, H., et al. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00523-1 · Cited by 263
Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F. T., & Benhattar, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10593 · Cited by 260 · cited 1×
“DNA methylation, which is a reversible modication of DNA structure, adding a methyl group to the 5′ position f a cytosine residue, often as part of a CpG island or cluster [63], f tumor suppressor genes including APC, CDKN2, BRCA1, Rb and infection and drive inflammation in the lungs.”
BackgroundChronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Adcock, I. M., Caramori, G., & Barnes, P. J. (2011) · Respiration · doi:10.1159/000324601 · Cited by 257 · cited 1×
“Additionally NO can increase angiogenesis through vascular endothelial growth factor (VEGF) stimulation and increases tumor growth and cell invasion properties [37].”
BackgroundSelf-citationOxidative DNA base damage and antioxidant enzyme activities in human lung cancer
Jaruga, P., Zastawny, T. H., Skokowski, J., Dizdaroglu, M., & Olinski, R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80240-8 · Cited by 242
Variable DNA Methylation Is Associated with Chronic Obstructive Pulmonary Disease and Lung Function
Qiu, W., Baccarelli, A., Carey, V. J., Boutaoui, N., Bacherman, H., Klanderman, B., Rennard, S., Agusti, A., Anderson, W., Lomas, D. A., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1382oc · Cited by 239
Ngkelo, A., Meja, K., Yeadon, M., Adcock, I., & Kirkham, P. A. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-1 · Cited by 238
Self-citationRole of miRNA-146a in the regulation of the innate immune response and cancer
Williams, A. E., Perry, M. M., Moschos, S. A., Larner-Svensson, H. M., & Lindsay, M. A. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361211 · Cited by 226
Papi, A. (2004) · Thorax · doi:10.1136/thx.2003.018291 · Cited by 223
Bhadury, J., Nilsson, L. M., Veppil Muralidharan, S., Green, L. C., Li, Z., Gesner, E. M., Hansen, H. C., Keller, U. B., McLure, K. G., & Nilsson, J. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406722111 · Cited by 212
Telomere length and the risk of lung cancer
Jang, J. S., Choi, Y. Y., Lee, W. K., Choi, J. E., Cha, S. I., Kim, Y. J., Kim, C. H., Kam, S., Jung, T. H., & Park, J. Y. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00831.x · Cited by 210
Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD
Ford, P. A., Durham, A. L., Russell, R. E. K., Gordon, F., Adcock, I. M., & Barnes, P. J. (2010) · Chest · doi:10.1378/chest.09-2363 · Cited by 190
Self-citationUnbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer
Caramori, G., Adcock, I. M., Casolari, P., Ito, K., Jazrawi, E., Tsaprouni, L., Villetti, G., Civelli, M., Carnini, C., Chung, K. F., et al. (2011) · Thorax · doi:10.1136/thx.2010.156448 · Cited by 187
Self-citationKirkham, P. A., Caramori, G., Casolari, P., Papi, A. A., Edwards, M., Shamji, B., Triantaphyllopoulos, K., Hussain, F., Pinart, M., Khan, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1605oc · Cited by 186
Self-citationBaarsma, H. A., Spanjer, A. I. R., Haitsma, G., Engelbertink, L. H. J. M., Meurs, H., Jonker, M. R., Timens, W., Postma, D. S., Kerstjens, H. A. M., & Gosens, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025450 · Cited by 172
Wang, H., Zhang, H., Tang, L., Chen, H., Wu, C., Zhao, M., Yang, Y., Chen, X., & Liu, G. (2013) · Toxicology · doi:10.1016/j.tox.2012.09.017 · Cited by 165
Pacheco-Pinedo, E. C., Durham, A. C., Stewart, K. M., Goss, A. M., Lu, M. M., DeMayo, F. J., & Morrisey, E. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44871 · Cited by 164
Self-citationCharest, A., Wilker, E. W., McLaughlin, M. E., Lane, K., Gowda, R., Coven, S., McMahon, K., Kovach, S., Feng, Y., Yaffe, M. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1193 · Cited by 163
Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2
Osoata, G. O., Yamamura, S., Ito, M., Vuppusetty, C., Adcock, I. M., Barnes, P. J., & Ito, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.128 · Cited by 159
Self-citationIto, K., Caramori, G., & Adcock, I. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111674 · Cited by 159
Self-citationDownregulation of the Serum Response Factor/MiR-1 Axis in the Quadriceps of Patients with COPD
Lewis, A., Riddoch-Contreras, J., Natanek, S. A., Donaldson, A., Man, W. D.-C., Moxham, J., Hopkinson, N. S., Polkey, M. I., & Kemp, P. R. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200309 · Cited by 156
Young, R. P., Duan, F., Chiles, C., Hopkins, R. J., Gamble, G. D., Greco, E. M., Gatsonis, C. A., & Aberle, D. R. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0894oc · Cited by 151
Epigenetic biomarkers in lung cancer
Liloglou, T., Bediaga, N. G., Brown, B. R. B., Field, J. K., & Davies, M. P. A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.018 · Cited by 148
Zhang, D., Pan, Y., Zhang, C., Yan, B., Yu, S., Wu, D., Shi, M., Shi, K., Cai, X.-X., Zhou, S., et al. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1498-1 · Cited by 147
Schwartz, A. G., & Ruckdeschel, J. C. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-235pp · Cited by 139
N‐acetylcysteine – passe‐partout or much ado about nothing?
Aitio, M. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02523.x · Cited by 134
Sohal, S. S., Reid, D. W., Soltani, A., Ward, C., Weston, S., Muller, H. K., Wood-Baker, R. R., & Walters, E. H. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-130 · Cited by 132
de Boer, W. I., Hau, C. M., van Schadewijk, A. M., Stolk, J. N., van Krieken, J. H. J. M., & Hiemstra, P. S. (2005) · American Journal of Clinical Pathology · doi:10.1309/w1ax-kgt7-ua37-x257 · Cited by 120
Genetic susceptibility to lung cancer and co-morbidities.
Yang, I. A., Holloway, J. W., & Fong, K. M. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.08.06 · Cited by 106
Lifetime probability of developing lung cancer, by smoking status, Canada
Villeneuve, P. J., & Mao, Y. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)90149-3 · Cited by 105
Stefano, A. D., Caramori, G., Gnemmi, I., Contoli, M., Bristot, L., Capelli, A., Ricciardolo, F. L. M., Magno, F., D’Anna, S. E., Zanini, A., et al. (2009) · Thorax · doi:10.1136/thx.2009.113647 · Cited by 104
Self-citationSpecific peripheral miRNA profiles for distinguishing lung cancer from COPD
Leidinger, P., Keller, A., Borries, A., Huwer, H., Rohling, M., Huebers, J., Lenhof, H., & Meese, E. U. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.02.003 · Cited by 101
Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility
Hosgood, H. D., Cawthon, R., He, X., Chanock, S. J., & Lan, Q. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.02.005 · Cited by 94
Abouharb, S., & Moulder, S. (2015) · Current Oncology Reports · doi:10.1007/s11912-014-0431-z · Cited by 86
Frías-López, C., García-Aranda, C., de Juan, C., Morán, A., Ortega, P., Gómez, A., Hernándo, F., López-Asenjo, J. A., Torres, A.-J., Benito, M., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.11.001 · Cited by 85
Genetic Loci Influencing Lung Function: A Genomewide Scan in the Framingham Study
Joost, O., Wilk, J. B., Cupples, L. A., Harmon, M., Shearman, A. M., Baldwin, C. T., O’Connor, G. T., Myers, R. H., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2102057 · Cited by 79
Oxidized guanine lesions and hOgg1 activity in lung cancer
Mambo, E., Chatterjee, A., de Souza-Pinto, N. C., Mayard, S., Hogue, B. A., Hoque, M. O., Dizdaroğlu, M., Bohr, V. A., & Sidransky, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208669 · Cited by 78
Vulimiri, S. V., Wu, X., Baer‐Dubowska, W., de Andrade, M., Detry, M. A., Spitz, M. R., & DiGiovanni, J. (2000) · Molecular Carcinogenesis · Cited by 77
Ellis, P. M., Coakley, N., Feld, R. D., Kuruvilla, S., & Ung, Y. (2015) · Current Oncology · doi:10.3747/co.22.2566 · Cited by 75
Epigenetics in asthma and COPD
Kabesch, M., & Adcock, I. M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.017 · Cited by 73
Self-citationSato, T., Arai, E., Kohno, T., Takahashi, Y., Miyata, S., Tsuta, K., WATANABE, S.-I. I., Soejima, K., Betsuyaku, T., & Kanai, Y. (2013) · International Journal of Cancer · doi:10.1002/ijc.28684 · Cited by 70
Rosenberger, A., Illig, T., Korb, K., Klopp, N., Zietemann, V., Wölke, G., Meese, E. U., Sybrecht, G. W., Kronenberg, F., Cebulla, M., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-60 · Cited by 64
The Role of Anti-angiogenesis in Non-small-cell Lung Cancer: an Update
Villaruz, L. C., & Socinski, M. A. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0448-y · Cited by 63
Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer
Tessema, M., Yingling, C. M., Picchi, M. A., Wu, G., Liu, Y., Weissfeld, J. L., Siegfried, J. M., Tesfaigzi, Y., & Belinsky, S. A. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000592 · Cited by 61
Chronic Obstructive Pulmonary Disease and Lung Cancer: A Lethal Association
Barnes, P. J., & Adcock, I. M. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1436ed · Cited by 60
Self-citationGinsberg, M. S. (2005) · Seminars in Roentgenology · doi:10.1053/j.ro.2005.01.007 · Cited by 60
Islam, K. N., & Mendelson, C. R. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0412 · Cited by 58
Link between COPD and lung cancer
Young, R. P., & Hopkins, R. J. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2009.11.025 · Cited by 56
Mitochondrial dynamics: biology and therapy in lung cancer
Lennon, F. E., & Salgia, R. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.899350 · Cited by 55
Tse, H. N., & Tseng, C. Z. S. (2014) · International Journal of COPD · doi:10.2147/copd.s51057 · Cited by 53
Dyke, A. L. V., Coté, M. L., Wenzlaff, A. S., Chen, W., Abrams, J., Land, S. J., Giroux, C. N., & Schwartz, A. G. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0962 · Cited by 51
Lee, H. J., Seol, H. S., Kim, J. Y., Chun, S., Suh, Y., Park, Y.-S., Kim, S.-W., Choi, C., Park, S.-I., Kim, D. K., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2553-6 · Cited by 50
Ding, S., & Zheng, P. (2012) · Gut Pathogens · doi:10.1186/1757-4749-4-18 · Cited by 46
Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer
Jaruga, P., Zastawnya, T. H., Skokowski, J., et al. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)92220-9 · Cited by 45
Winn, L. M., Kim, P. M., & Nickoloff, J. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052639 · Cited by 43
McErlean, A., & Ginsberg, M. S. (2011) · Seminars in Roentgenology · doi:10.1053/j.ro.2011.02.002 · Cited by 42
Protein Carbonylation and Decarboylation
Cattaruzza, M., & Hecker, M. (2008) · Circulation Research · doi:10.1161/circresaha.108.172148 · Cited by 40
Mechanisms of tumor promotion by reactive oxygen species
Kobliakov, V. A. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910060015 · Cited by 39
Bartolotti, M., Franceschi, E., & Brandes, A. A. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.121 · Cited by 37
Peng, H., Yang, M. H., Chen, Z.-Y., Chen, P., Guan, C., Xiang, X.-D., Cai, S., Chen, Y., & Fang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082739 · Cited by 34
Jamalkandi, S. A., Mirzaie, M., Jafari, M., Mehrani, H. A., Shariati, P., & Khodabandeh, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.07.005 · Cited by 32
Lifetime and Age-Conditional Probabilities of Developing or Dying of Cancer in Japan
Kamo, K., Katanoda, K., Matsuda, T., Marugame, T., Ajiki, W., & Sobue, T. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn061 · Cited by 25
Vastagh, E., Kuna, P., Calistru, P. I., & Bogdan, M. A. (2003) · Respiratory Medicine · doi:10.1016/j.rmed.2003.10.001 · Cited by 21
Wang, H., Li, Y., Deng, J., Wang, B., Yang, X., Yang, R., Cheng, M., Fang, W., Qiu, F., Zhang, X., et al. (2014) · Mutagenesis · doi:10.1093/mutage/geu020 · Cited by 15
Complex Role of Histone Deacetylase Inhibitors in the Treatment of Non–Small-Cell Lung Cancer
Neal, J. W., & Sequist, L. V. D. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0860 · Cited by 15
Cited by
The global burden of lung cancer: current status and future trends
Leiter, A., Veluswamy, R. R., & Wisnivesky, J. P. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00798-3 · Cited by 1,477
Chronic obstructive pulmonary disease
Rabe, K. F., & Watz, H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31222-9 · Cited by 960
SpiroMeta Consortium, McKay, J. D., Hung, R. J., Han, Y., Zong, X., Carreras-Torres, R., Christiani, D. C., Caporaso, N. E., Johansson, M., Xiao, X., et al. (2017) · Nature Genetics · doi:10.1038/ng.3892 · Cited by 720
Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer
Tsay, J.-C. J., Wu, B. G., Badri, M. H., Clemente, J. C., Shen, N., Meyn, P., Li, Y., Yie, T.-A., Lhakhang, T., Olsen, E., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2118oc · Cited by 448
Chemotherapy: a double-edged sword in cancer treatment
Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-021-03013-3 · Cited by 397
Metadata
- Authors
- Durham, A. L., & Adcock, I. M.
- Venue
- Lung Cancer
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 90
- Issue
- 2
- Pages
- 121-127
- ISSN
- 0169-5002 (ISSN-L)
- OpenAlex
- W1883683241
- Cited by
- 451
- References
- 105
- FWCI
- 18.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.